The IBRI is continuing on the ambitious path that was envisioned when it was founded several years ago. With the arrival of our new president and CEO Alan Palkowitz, PhD, the IBRI has now updated its strategic direction to align with today’s scientific opportunities and dynamic environment.
An important goal of the IBRI’s work is to enable innovation in the life sciences ecosystem, improve efficiency of therapeutic discovery and more quickly translate disease hypotheses into potential therapies that improve patient health outcomes here in Indiana and around the world.
